EXCEED THE SPACE PROVIDED. This study will investigate a novel gene delivery system that is based on the formation of sulfhydryl cross- links within peptide DNA condensates. The gene delivery system under investigation is a multi-component peptide condensed DNA formulation. The key components consist of plasmid DNA condensed by an add- mixture of peptide conjugates each containing multiple sulfhydryl groups designed to spontaneously polymerize and cross-link when bound to DNA. Following i.v. dosing, cross-linked DNA condensates are proposed to transiently stabilize plasmid DNA during circulation and inside the target cells. Cross-linking peptides will be covalently derivatized with a single polyethylene glycol (PEG) chain to form a steric layer on the surface of DNA condensates that blocks protein binding and masks DNA condensate recognition by the reticuloendothelial system. Targeting specificity will be achieved by derivatizing a cross-linking peptide with a single N-glycan resulting in glycopeptides that direct targeting to either the asialoglycoprotein receptor on hepatocytes or the mannose receptor on Kupffer cells. DNA condensates will be prepared using binary add- mixtures of cross-linking glycopeptide and PEG-peptide. Cross-linking peptides will be modified to buffer endosomes and allow DNA condensates to release into the cytosol of target cells. Once in the cytosol, cross- linked DNA condensates are proposed to slowly release plasmid DNA following disulfide bond reduction. The central hypothesis to be tested is that increasing DNA condensate stability and controlling the rate of DNA release into the cytosol will prolong the half-life of DNA and produce higher levels of gene expression in vivo. These studies aim to systematically optimize the level of transient gene expression in vivo using a novel chemical mechanism to overcome barriers that currently limit the efficiency of nonviral gene delivery systems. PERFORMANCE SITE ========================================Section End===========================================
| Rettig, Garrett R; Rice, Kevin G (2009) Quantitative in vivo imaging of non-viral-mediated gene expression and RNAi-mediated knockdown. Methods Mol Biol 574:155-71 |
| Martin, Molly E; Rice, Kevin G (2007) Peptide-guided gene delivery. AAPS J 9:E18-29 |
| McAnuff, Marie A; Rettig, Garrett R; Rice, Kevin G (2007) Potency of siRNA versus shRNA mediated knockdown in vivo. J Pharm Sci 96:2922-30 |
| Chen, Chang-po; Kim, Ji-seon; Liu, Dijie et al. (2007) Synthetic PEGylated glycoproteins and their utility in gene delivery. Bioconjug Chem 18:371-8 |
| Chen, Chang-Po; Kim, Ji-seon; Steenblock, Erin et al. (2006) Gene transfer with poly-melittin peptides. Bioconjug Chem 17:1057-62 |
| Rettig, Garrett R; McAnuff, Marie; Liu, Dijie et al. (2006) Quantitative bioluminescence imaging of transgene expression in vivo. Anal Biochem 355:90-4 |
| Chen, C-P; Park, Y; Rice, K G (2004) An improved large-scale synthesis of PEG-peptides for gene delivery. J Pept Res 64:237-43 |
| Kwok, Kai Y; Park, Youmie; Yang, Yongsheng et al. (2003) In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates. J Pharm Sci 92:1174-85 |
